23 Jun 2016
On June 15, 2016, Global News reported on the International Agency for Research on Cancer’s (IARC) re-evaluation of the carcinogenicity of coffee. OCRC’s Dr. Paul Demers provided Global News with commentary on how IARC evaluates carcinogenicity and what its classifications mean.
IARC downgraded coffee from a Group 2B possible carcinogen to Group 3, not classifiable as to its carcinogenicity to humans. The IARC Working Group found no consistent, reliable evidence that coffee increases the risk of cancer.
Results from a study by OCRC and the Institute for Work and Health.
We are pleased to share our annual report, highlighting progress and accomplishments from 2023-2024. The theme of this report is…
In celebration of International Women’s Day this March 8th, OCRC would like to spotlight some of our research that focuses…
